A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Study Identifier
GMA-SIM-14-024
CT.gov Identifier
NCT02348476
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Participants treated with Simbrinza™ for Intra-Ocular Pressure (IOP) lowering in at least one eye * Participants who had at least one-follow-up visit with tolerablity and efficacy data after Simbrinza™ treatment initiation.
    Exclusion Criteria:
    * Active ocular disease other than glaucoma or ocular hypertension * History of any intraocular surgery or glaucoma laser surgery within 3 months.

    Protocol Summary

    This study is a retrospective chart review to assess the tolerability and efficacy of treatment with Simbrinza™ used for patients with Open-Angle Glaucoma or Ocular Hypertension.

    Study Locations

    Location
    Status
    Location
    Wheaton, Illinois, United States
    Status
    Not applicable